FOR HER
Your dedication to saving women’s lives
is what drives us to offer
FDA-approved
Aptima® HPV
mRNA Assay
mRNA Assay
One of the most significant innovations in
cervical cancer screening in over a decade.
Know the facts about the Aptima HPV Test
- Offers excellent sensitivity
- Offers increased specificity2
- FDA-approved for use with ThinPrep®
- Aligns with cervical cancer screening guidelines
- Requires only 1 mL of specimen2
- Same price and coverage as DNA-based HPV tests
- No increased costs to you or your patients
- Only assay to genotype 16, 18/45 to identify almost
all HPV types associated with cervical adenocarcinoma
- The ASCUS Study population included 939 women <21 years with ASCUS cytology results
- The NILM (Adjunct) Study population included 10,871 women <30 years with normal cytology results